Since CD40/CD40 ligand (CD40Lig) interactions are essential in vivo for the generation of germinal center B cells that express Fas (Apo-1/CD95), we explored whether CD40 engagement may modulate Fas expression and function on human B lymphocytes. Resting tonsil B cells, isolated by density gradient centrifugation, express either absent or low levels of Fas. They could be induced to promptly express Fas after ligation of their CD40, however, using either a recombinant human CD40Lig or a cross-linked anti-CD40 mAb. In contrast, engagement of the B cell antigen receptor by immobilized anti-K and -k antibodies did not turn on Fas expression. Addition of anti-Fas mAb CH11 inhibited the later phases of CD40-induced B cell growth as a result of apoptotic cell death. Furthermore, Fas ligation inhibited proliferation and Ig secretion of CD40-activated B cells in response to recombinant cytokines such as interleukin (IL)-2, IL-4, and IL-10, as well as a cytokine-rich supernatant ofphytohemagglutinin-activated T cells, indicating that none of those B cell tropic factors were able to prevent the Fas-induced death. Taken together, the present results show that engagement of CD40 antigen on B cells induces Fas expression and sensitizes them to Fas-mediated apoptosis. The delayed functional response to Fas ligation after CD40 activation may represent a way to limit the size of a specific B cell clone that is generated during T-B cell interactions.
T
o mount efficient humoral immune responses against the innumerable pathogens that a living organism may encounter, numerous specific B cell clones should be available at any given time, consequently imposing each a very limited size. The in~rnune system must have therefore established safe systems to avoid the overrepresentation of only a few clones. Accordingly, the survival, growth, and death of cells is highly controlled in vivo through surface molecules that bind ligands which may be either soluble or membrane-bound polypeptides (1, 2) . In particular, the CD40 receptor and the Fas (Apo-1/CD95) receptor represent two members of the TNF receptor superfamily that are expressed on several cell types (3) (4) (5) . Although these two receptors display a comparable overall structure, their triggering results in opposite effects on cell growth. While CD40 acts as a growth/survival trigger for B cells (6) , Fas principally acts as a death trigger for activated T and B cells (7, 8) .
Ligation of the Fas molecule by functional antibodies or by its ligand (FasLig) 1 induces death of sensitive cells through an apoptotic process (9) (10) (11) (12) . The Fas/FasLig sys- tem has been demonstrated to participate in the activationinduced death of mature T cells that may prevent the development of autoreactive T cells and control T cell--dependent immune responses in vivo (13) (14) (15) . This concept is best illustrated by the lymphoproliferative and autoimmune disease observed in Ipr and gld mice that are deficient for Fas and FasLig, respectively (16) (17) (18) . Interaction between FasLig expressed on cytotoxic T cells and Fas on target cells also represents a cytolysis mechanism that complements the perforin/granzyme pathway (19, 20) .
When considering mature B lymphocytes, Fas is expressed at high level on B cells in germinal centers of secondary lymphoid organs, where massive B cell proliferation, somatic mutations within Ig variable region gene, and antigen-driven selection of high affnity B cells occur (21) (22) (23) . Germinal center B cells are characterized by their rapid entry into spontaneous apoptosis, a process that can be prevented by CD40 ligation but accelerated by Fas triggering (22, 24) . In contrast, most resting B cells express no or low level of Fas and are not prone to apoptosis (22, 23, 25) . Since CD40-CD40Lig interaction appears necessary to induce the formation of germinal centers (26) (27) (28) , we wondered whether CD40 activation of B lymphocytes may modulate Fas expression and function. Herein we show that CD40 engagement induces resting tonsil B cells to ex-press high levels of Fas antigen, which ligation induces death by apoptosis. This results in inhibition of the later stages of CD40-induced B cell growth and differentiation. Thus, the function of Fas on B cells prevails over that of CD40 and is therefore likely to control the expansion of antigen-specific B cell clones.
Materials and Methods
Cytokines, Factors, and Culture Medium. Purified human rlL-4
(107 U/mg) and rlL-10 (2 • 107 U/rag) were from ScheringPlough Research Institute (Kenilworth, NJ) and were used at 50 U/ml and 50 ng/ml, respectively. Purified human rlL-2 (Amgen Biologicals, Thousand Oaks, CA) was used at 10 U/ml. A conditioned medium of activated mononuclear cells was produced by stimulating PBMC (2 • 106 cells/M) with 1 I.zg/ml PHA (Murex Diagnostics, Dartford, UK) for 3 d and is referred to as PHA-sup. M1 cultures were performed in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10% heat-inactivated FCS (GIBCO BILL, Gaithersburg, MD), and 50 lag/ml gentamycin (Schering-Plough, Levallois-Perret, France).
Antibodies. 
Fibroblastic L Cells and Human CD4OLig
Constructs. Mouse fibroblastic L cells stably transfected with the human CD32/ Fc-~/ILII (CD32-L cells) have been previously described (29) . For generation of L cells stably transfected with the human CD40Lig (CD40Lig-L cells), the CD40Lig cDNA (30) was amplified by PCIL using the following primers: forward 5'-CGCTAACGT-TCTCGAGCTTTAACACAGCATGATCGAA-3 and reverse 5'-CATTGTGATGCGGCCGCTCAGAGTTTGAGTAAGCC-AAA-3', introducing Xhol and Not1 restriction sites, respectively (restriction sites are underlined). PCR amplification (Perkin-Elmer Cetus, Oakland, CA) was performed by 35 cycles of the following scheme: 1 rain denaturation at 94~ 2 min anealing at 60~ and 3 min primer extension at 72~ The PCR product was then digested, gel purified, and cloned into the expression plasmid pME18S-neo, which contains the neomycin resistance gene. Mouse L cells (7 X 106) were then transfected with 20 Fxg of the resulting expression plasmid pME 18S-neo-CD40Lig using electroporation (220 V, 960 laF; Gene Pulser; Bio lKad Laboratories, ILichmond, CA). After electroporation, neomycin-resistant L cells were selected in ILPMI 1640, 10% FCS containing 0.5 mg/ml G418 (GIBCO), and CD40Lig-expressing cells were further isolated by three rounds of sorting on a FACStarP lus| (Becton Dickinson & Co.) after staining with a CD40-Fc chimeric molecule (31) . For generation of a soluble CD40Lig-mouse CD8cr fusion protein (CD40Lig-mCD8), the extracellular region of mouse CD8cx was first amplified by reverse transcription PCIK from total IKNA of the mouse T cell line CTLL-2 using the following primers: forward 5'-GCTAACGTTCTCGAGGGAGAG-CACACCATGGCCTCA-3' and reverse 5'-GCTAACGTTCT-GCAGTCGACATCACAGGCGAAGTCCAATCC-3 ' introducing the XhoI and Pstl sites, respectively (sites are underlined). The PCR amplification was performed as described above. After digestion and purification, the PCR product was cloned into the expression plasmid pME18S. By the PCR reaction, a unique Sail site was introduced directly adjacent to the 3' end of the CD8~ gene (indicated in bold). Next, the extracellular region of human CD40Lig was PCIL amplified from CD40Lig cDNA using the following primers: forward 5'-GCTAACGTTGTCGACGTC-AGAAGGTTGGACAAGATAGAA-3' and reverse 5'-CAT-TGTGATGCGGCCGCTCAGAGTTTGAGTAAGCCAAA-3', introducing a SalI and NotI restriction site, respectively (sites are underlined). The forward primer in addition introduced the sequence GTC (indicated in bold). PCIL reaction was perfomled as described above, and the PCR product was digested, purified, and cloned into the plasmid pME18S-mCDS. By this procedure, the mCI)8cx and hCD40Lig are cloned in frame with a linker sequence of GTCGACGTC that contains both Sail and Aatll sites, and coding for the peptide Val-Asp-Val. COS cells (7 • 106) were then transfected with 20 lag of the final expression plasmid pME18S-mCD8-CD40Lig using electroporation and grown in RPMI 1640, 1% Nutridoma HU (Boehringer Mannheim GmbH, Mannheim, Germany). After 4 d of culture, COS cell supernatant was harvested, centrifuged, and filtrated on a 0.2-btm filter. This expressed soluble CD40Lig-mCD8 construct was found to be functional, as determined by its specific binding on CI)40-expressing human B cells atier staining with FITC-conjugated rat anti-mCD8ot mAb (Boehringer Mannheim) and flow cytometric analysis.
B Cell Preparations.
Total normal B cells were purified from tonsils as described earlier (32) . Briefly, mononuclear cells separated by standard Ficoll-Hypaque gradient were first rosetted with SRBC. Nonrosetting cells were further incubated with anti-CD2, anti-CD3, and anti-CD14 n~a~bs, and were then submitted to negative selection performed with magnetic beads coated with anti-mouse lgG (Dynabeads; Dynal, Oslo, Norway). Purified B cell preparations contained >98% B cells and <2% T cells and monocytes, as determined by staining with FITC-conjugated anti-CD19, anti-CD20, anti-CD2, anti-CD3, and anti-CD14 mAbs, and fluorescence analysis performed with a FACScan ~ (Becton Dickinson & Co.). Total tonsil B cells were further separated according to their size using a discontinuous gradient of Percoll (Pharmacia, Uppsala, Sweden) consisting of three layers of Percoll solutions in a 15-ml conical tube (4 ml of 65% [1. 085 g/ ml], 4 ml of 55% [1.075 g/ml], and 2 ml of 35% [1.050 g/ml]). 5 • 107 B cells were overlaid on the top of the gradient and centrifuged for 20 min at 550 g at 20~ B cells recovered at the interface of 35-55% layers were referred to as low density B cells, and cells recovered at the interface of 65-55% Percoll solutions were referred to as high density or resting B cells. 
Analysis of Fas Expression.

Results
CD40 Engagement Induces Fas Expression on Resting Human B Cells. Human tonsillar B lymphocytes contain a subpopulation of cells expressing Fas that represent 30-40%
of total B cells (Fig. 1 A) . They are essentially low density germinal center B cells (22, 23, 35) . Accordingly, Fig. 1 A shows that the low density tonsillar B cells obtained by Percoil gradient centrifugation contained 40-60% Fas + ceils, while high density (resting) B cells contained ~5% Fas + cells (mean of five experiments).
To determine the signals required for Fas induction, resting tonsil B cells were cultured on irradiated CD40Lig-L cells and Fas expression was determined at different time points by flow cytometric analysis. As shown in Fig. 1 B, CD40 activation induced B cells to express Fas. Fas could be detected on the B cell surface as early as 12 h after CD40 activation, and its expression further increased with time. All B cells expressed Fas after 48 h with a maximal and stable intensity between 3 and 5 d of culture. To rule out a possible role of the fibroblastic L cell, resting B cells were cultured with a soluble human CD40Lig-mouse CDSIx fusion protein (CD40Lig-mCD8). As shown in Fig. 1 C, 
The CD40-dependent induction of Fas expression is not a mere indication of B cell activation inasmuch as engagement of resting B cell antigen receptor, using immobilized anti-K and anti-X mAbs, did not turn on Fas expression (Fig. 2) , while it induced short-term DNA synthesis (data not shown). resting B cells were cultured on CD40Lig-L cells in the presence of the anti-Fas mAb CH11, a functional IgM mAb that induces cell death when used in a soluble form (10) . Increasing concentrations of anti-Fas mAb were added at the onset of the culture, and B cell proliferation was measured by [3H]TdR uptake on day 6. As shown in Fig. 3 A, anti-Fas mAb inhibited CD40-dependent B cell proliferation in a dose-dependent manner, with an optimum at ~0.1 Ixg/rnl anti-Fas mAb CH11, a concentration that induces maximal growth arrest and death of sensitive cell lines (3, 10) . The time kinetics of [3H]TdR uptake, however, indicated that anti-Fas only weakly affected B cell proliferation during the first 3 d of culture, while the late DNA synthesis (days 4-9) was progressively blocked (Fig. 3 B) . Fas ligation thus antagonizes the later stages of CD40-dependent B cell DNA synthesis. (Fig. 3 D) . Giemsa staining performed on 3-d CD40-activated B cells revealed the presence of cells exhibiting morphological features of apoptosis (chromatin condensation and fragmentation) as early as 2 h after anti-Fas treatment, and a 4-h contact with anti-Fas mAb resulted in an increased incidence of apoptotic cells (Fig. 4) . Moreover, typical "ladder" patterns of internucleosomal DNA cleavage were observed on electrophoresis from DNA of CD40-preactivated B cells further cultured with anti-Fas for 2, 4, and 6 h, but not with a control antibody (Fig. 5) .
Cross-linking Fas Molecules Inhibits the Later
Fas Engagement Induces Apoptosis of CD40-activated B
Taken together, these results indicate that Fas triggering of CD40-activated B cells induces endonuclease activity and death by apoptosis. 
Fas Ligation Blocks Cytokine-induced Proliferation and lg
Discussion
The present study demonstrates that CD40 triggering readily turns on Fas expression on resting B cells and that further Fas ligation prevails over CD40 engagement, since B cells that undergo the dual triggering enter into apoptosis.
This study focused attention on the analysis of Fas-B cells in culture that have been negatively selected by density gradient centrifugation because positive selection (e.g., using antibodies to surface IgD for selecting Fas-naive B cells) could have induced subsequent alteration of Fas expression and B cell death/survival (37, 38) . Maximal Fas expression, reached after 48-72 h of activation, requires an optimal ligation of the CD40 molecule that can be achieved either by CD40Lig stably expressed on fibroblastic L cells or by cross-linking a soluble CD40Lig-CD8 fusion protein with anti-CD8 mAb. Accordingly, an anti-CD40 antibody had to be cross-linked with CD32-L cells (CD40 system) (39) for inducing Fas expression on resting B cells (data not shown). In keeping with this, all the experiments presented herein with the CD40Lig-L cells have been reproduced using the CD40 system (data not shown). Consistent with the expression of CD40Lig on activated T cells (31, 40, 41) , anti-CD3 activated T cells were also found to readily induce Fas expression on B cells (data not shown). While considerable Fas expression could be observed after 24-48 h of CD40 activation, a functional response to Fas triggering could only be seen after 3 d of activation, since B cells costimulated through both CD40 and Fas display reduced growth and the first signs of cell death only after 3 d of culture. Such a delayed establishment of Fas sensitivity has been previously described for normal B cells activated with pokeweed mitogen (42) , for leukemic B ceils activated with a combination of Staphylococcus aureus particles and IL-2 (43), and for mitogen-activated T cells (44, 45) . The cell susceptibility to Fas-mediated killing was previously associated with an inverse expression of the antiapoptotic intracellular Bcl-2 protein (43, 46, 47) . Though a slight decrease in Bcl-2 protein expression was observed in B cells activated for more than 3 d through their CD40 (data not shown), this does not permit us to account for the susceptibility of B cells to Fas ligation. This may be explained by the numerous genes that appear to be involved in the control of cell survival (48, 49) . Thus, a thorough analysis aimed at understanding the establishment of B cell susceptibility to Fas ligation will require the availability of antibodies specific for these gene products because the death/survival decision depends on the balance between these proteins.
An efficient T cell-dependent humoral immune response against one specific antigen is initiated when APCs and B cells present the processed antigen to T cells in an MHC-restricted fashion. T cells activated through their TCR./CD3 complex are induced to express CD40Lig and to secrete cytokines that in turn induce CD40-dependent B cell proliferation (6, 50) . TCR engagement, however, can induce FasLig expression on T cells (13) (14) (15) 51) Thus, during T cell encounter, an antigen-selected B cell (e.g., in the germinal center light zone) will undergo CD40 activation that leads to clonal expansion and seeding of daughter B cells that will eventually differentiate into plasma blasts and/or memory B cells (56) . The initial B cell of the clone will then be eliminated by apoptosis after a prolonged Fas engagement. The CD40-induced upregulation of Fas expression, associated to a delayed functional FasLig responsiveness, may therefore represent a way to limit the expansion of a given B cell clone. A dysfunction of this Fas system will result in the generation of a predominant clone that will compete with the multiple B cell clones required for appropriate humoral responses. Complementary findings on the upregulation of functional Fas expression on B lymphocytes activated through their CD40 antigen have been reported in two recent studies (57, 58) .
In conclusion, CD40 triggering turns on Fas expression on B cells that undergo apoptosis after subsequent Fas engagement. The Fas system may thus represent a safeguard system that operates not only on T cells, but also at the B cell level, and may permit to limit the B cell clone size during T cell-dependent humoral immune responses.
